PROVIDER PROFILE · NPI 1194166520

Megan Rowland

Nurse PractitionerVersailles, MOI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

3,692

Beneficiaries

—

Total drug cost

$175K

Distinct drugs

Brand share

16.5%

Top prescribed drugs

Albuterol Sulfate167 claims

Lisinopril162 claims

Tramadol Hcl157 claims

Levothyroxine Sodium147 claims

Gabapentin142 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$195

Payment records

By payment type

Food and Beverage$195

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 260141

Hospital

REFERRAL NETWORK

Where Megan Rowland's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
REGIONAL HEALTH CARE CLINIC, INC	76	247
Mary Dimarsico Family Practice · Versailles, MO	39	162
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	30	58
CURATORS OF THE UNIVERSITY OF MISSOURI	19	53

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	50	130
REGIONAL HEALTH CARE CLINIC, INC	31	67
Mary Dimarsico Family Practice · Versailles, MO	24	96
CURATORS OF THE UNIVERSITY OF MISSOURI	16	38
BOTHWELL REGIONAL HEALTH CENTER	16	39

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history